NEW YORK — AstraZeneca is not backing away from China despite an investigation into its president of China operations.
As the company reported its third-quarter earnings …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Spexis AG / Key word(s): Miscellaneous 29-Nov-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely
Note that some links may require registration or subscription. A new special of the TV show “South Park” will take on the rising use of
Adding perioperative durvalumab (Imfinzi) to neoadjuvant chemotherapy significantly improved survival outcomes in cisplatin-eligible patients with muscle-invasive bladder cancer (MIBC), a phase III trial showed. Estimated